These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17508544)

  • 1. [SERCA2a (SR Ca(2+)-ATPase)].
    Arai M
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():92-6. PubMed ID: 17508544
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement in cardiac function after sarcoplasmic reticulum Ca2+-ATPase gene transfer in a beagle heart failure model.
    Mi YF; Li XY; Tang LJ; Lu XC; Fu ZQ; Ye WH
    Chin Med J (Engl); 2009 Jun; 122(12):1423-8. PubMed ID: 19567165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcalumenin alleviates stress-induced cardiac dysfunction by improving Ca2+ handling of the sarcoplasmic reticulum.
    Shimura M; Minamisawa S; Takeshima H; Jiao Q; Bai Y; Umemura S; Ishikawa Y
    Cardiovasc Res; 2008 Jan; 77(2):362-70. PubMed ID: 18006473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology.
    Periasamy M; Bhupathy P; Babu GJ
    Cardiovasc Res; 2008 Jan; 77(2):265-73. PubMed ID: 18006443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sarcoplasmic reticulum function and heart failure: a novel therapeutic target for heart failure].
    Minamisawa S; Ikeda Y
    Clin Calcium; 2006 Jan; 16(1):37-44. PubMed ID: 16397349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic heart failure by overexpressing sarcoplasmic reticulum calcium ATPase through gene therapy: an experiment with rats].
    Li XY; Hui HP; Lu XC; Guo YT
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1174-8. PubMed ID: 16796857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure.
    Kawase Y; Ly HQ; Prunier F; Lebeche D; Shi Y; Jin H; Hadri L; Yoneyama R; Hoshino K; Takewa Y; Sakata S; Peluso R; Zsebo K; Gwathmey JK; Tardif JC; Tanguay JF; Hajjar RJ
    J Am Coll Cardiol; 2008 Mar; 51(11):1112-9. PubMed ID: 18342232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of left ventricular mechanics by recirculation-mediated AAV2/1-SERCA2a gene delivery in experimental heart failure.
    Mariani JA; Smolic A; Preovolos A; Byrne MJ; Power JM; Kaye DM
    Eur J Heart Fail; 2011 Mar; 13(3):247-53. PubMed ID: 21289077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure.
    Lokuta AJ; Maertz NA; Meethal SV; Potter KT; Kamp TJ; Valdivia HH; Haworth RA
    Circulation; 2005 Mar; 111(8):988-95. PubMed ID: 15710754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer of the sarcoplasmic reticulum pump in the treatment of heart failure.
    Hasenfuss G
    Eur J Heart Fail; 2011 Mar; 13(3):245-6. PubMed ID: 21335446
    [No Abstract]   [Full Text] [Related]  

  • 11. The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases.
    Kawase Y; Hajjar RJ
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):554-65. PubMed ID: 18665137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcoendoplasmic reticulum calcium transport ATPase 2a: a potential gene therapy target in heart failure.
    Papolos A; Frishman WH
    Cardiol Rev; 2013; 21(3):151-4. PubMed ID: 23568057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors controlling the activity of the SERCA2a pump in the normal and failing heart.
    Vandecaetsbeek I; Raeymaekers L; Wuytack F; Vangheluwe P
    Biofactors; 2009; 35(6):484-99. PubMed ID: 19904717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats.
    Maier LS; Wahl-Schott C; Horn W; Weichert S; Pagel C; Wagner S; Dybkova N; Müller OJ; Näbauer M; Franz WM; Pieske B
    Cardiovasc Res; 2005 Sep; 67(4):636-46. PubMed ID: 15932750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.
    Schmitt JP; Ahmad F; Lorenz K; Hein L; Schulz S; Asahi M; Maclennan DH; Seidman CE; Seidman JG; Lohse MJ
    Circulation; 2009 Jan; 119(3):436-44. PubMed ID: 19139388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular mechanism underlying calcium handling in diastolic heart failure].
    Zhong M; Zhang Y; Zhang W
    Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):669-72. PubMed ID: 11798946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting SERCA2a as an innovative approach to the therapy of congestive heart failure.
    Ferrari P; Micheletti R; Valentini G; Bianchi G
    Med Hypotheses; 2007; 68(5):1120-5. PubMed ID: 17113239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals.
    Byrne MJ; Power JM; Preovolos A; Mariani JA; Hajjar RJ; Kaye DM
    Gene Ther; 2008 Dec; 15(23):1550-7. PubMed ID: 18650850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorcin interacts with sarcoplasmic reticulum Ca(2+)-ATPase and modulates excitation-contraction coupling in the heart.
    Matsumoto T; Hisamatsu Y; Ohkusa T; Inoue N; Sato T; Suzuki S; Ikeda Y; Matsuzaki M
    Basic Res Cardiol; 2005 May; 100(3):250-62. PubMed ID: 15754088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcoplasmic reticulum ATPase activity in type I and II skeletal muscle fibres of chronic heart failure patients.
    Bekedam MA; van Beek-Harmsen BJ; van Mechelen W; Boonstra A; Visser FC; van der Laarse WJ
    Int J Cardiol; 2009 Apr; 133(2):185-90. PubMed ID: 18279980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.